We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
South Africas Department of Health (DOH) Oct. 31 paved the way for pharma companies to raise prices for the first time in three years, a move that was greeted enthusiastically by industry.
European healthcare authorities and health and industry representatives agreed during a meeting Oct. 45 in Bad Hofgastein, Austria, to support the development of a permanent European Union Network for Health Technology Assessment (EUnetHTA).
The attorneys general of California and Alaska have issued subpoenas to AstraZeneca seeking information about its marketing practices for Seroquel (quetiapine fumarate), and the SEC has made an “informal inquiry” to the company regarding payments to foreign doctors and government officials, the company said.
An additional 3.8 million people without prescription drug coverage will be eligible for free drugs from AstraZeneca thanks to an expansion in the company’s Patient Assistance Program.
Drugstores are scrambling to defend their generic drug pricing policies following Wal-Mart’s announcement it would decrease the price of nearly 300 generic medicines to $4 for a 30-day supply.
Drug prices are becoming increasingly political with both the Democratic party and AARP releasing new reports a little less than two months before midterm elections.
Efforts by U.S. and South Korean trade officials to resolve differences in agriculture, anti-dumping measures, cars and medicines made little headway during recent negotiations in Seattle.
Encysive announced Aug. 11 that the European Commission has authorized it to market its hypertension drug Thelin in 100-mg tablets. The approval allows Encysive to market the drug in all 25 member states of the European Union (EU).